(Q57664903)

4

0 references

Kari Hemminki

7

object named as

Kari Hemminki

0 references

Jan Adolfsson

5

object named as

Jan Adolfsson

0 references

author name string

Shigeru Sakano

1

0 references

Petra Berggren

2

0 references

Erik Onelöv

6

0 references

Per Larsson

International Journal of Cancer

8

0 references

language of work or name

English

0 references

publication date

16 December 2002

0 references

published in

0 references

volume

104

0 references

issue

1

0 references

page(s)

98-103

0 references

cites work

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines.

21 January 2018

1 reference

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

Deletion of the p16 and p15 Genes in Human Bladder Tumors

21 January 2018

1 reference

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer

21 January 2018

1 reference

Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas.

21 January 2018

1 reference

Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.

21 January 2018

1 reference

CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma

21 January 2018

1 reference

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase

21 January 2018

1 reference

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population

21 January 2018

1 reference

Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications

21 January 2018

1 reference

The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

21 January 2018

1 reference

P16 gene in uncultured tumours

21 January 2018

1 reference

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

21 January 2018

1 reference

Molecular alterations in bladder cancer

21 January 2018

1 reference

Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder

21 January 2018

1 reference

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

21 January 2018

1 reference

Decreased expression of the p16/MTS1 gene without mutation is frequent in human urinary bladder carcinomas

21 January 2018

1 reference

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p

21 January 2018

1 reference

Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas

21 January 2018

1 reference

A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare

21 January 2018

1 reference

Analysis of G1/S checkpoint regulators in metastatic melanoma

21 January 2018

1 reference

Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas

21 January 2018

1 reference

Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes

21 January 2018

1 reference

DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference